Notice of Closed Meeting, 7761-7762 [2020-02693]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 28 / Tuesday, February 11, 2020 / Notices
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–CE–20–003, Research Grants for
Preventing Violence and Violence
Related Injury.
Date: April 1–2, 2020.
Time: 8:30 a.m.–5:30 p.m., EDT.
Place: Embassy Suites Buckhead,
3285 Peachtree Road NE, Atlanta, GA
30305.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Kimberly Leeks, Ph.D., M.P.H.,
Scientific Review Official, NCIPC, CDC,
4770 Buford Highway NE, Building 106,
MS S106–9, Atlanta, Georgia 30341,
Telephone: (770) 488–6562, KLeeks@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–02691 Filed 2–10–20; 8:45 am]
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–OH–20–002, Commercial Fishing
Occupational Safety Research
Cooperative Agreement; and RFA–OH–
20–003, Commercial Fishing
Occupational Safety Training Project
Grants.
Date: May 12, 2020.
Time: 1:00 p.m.–5:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Michael Goldcamp, Ph.D., Scientific
Review Officer, Office of Extramural
Programs, CDC, 1095 Willowdale Road,
Morgantown, West Virginia 26505,
Telephone: (304) 285–5951;
mgoldcamp@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Program: Protecting Patients from
Infections, Antibiotic Resistance and
Other Adverse Events; May 21, 2020,
10:00 a.m.–5:00 p.m., (EDT).
Teleconference, Centers for Disease
Control and Prevention, Room 1080, 8
Corporate Square Blvd., Atlanta, GA
30329 which was published in the
Federal Register on January 30, 2020,
Volume 85, Number 20, page 5440.
The meeting is being amended to
change the date to May 20–21, 2020.
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE, Mailstop US8–1,
Atlanta, Georgia 30329, (404) 718–8833,
gca5@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2020–02694 Filed 2–10–20; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
khammond on DSKJM1Z7X2PROD with NOTICES
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
VerDate Sep<11>2014
18:19 Feb 10, 2020
Jkt 250001
7761
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—RFA–CK–20–
004, Prevention Epicenters Program:
Protecting Patients From Infections,
Antibiotic Resistance and Other
Adverse Events
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP)—RFA–
CK–20–004, Prevention Epicenters
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–02695 Filed 2–10–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, pursuant to Public
Law 92–463. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
E:\FR\FM\11FEN1.SGM
11FEN1
7762
Federal Register / Vol. 85, No. 28 / Tuesday, February 11, 2020 / Notices
Control Special Emphasis Panel (SEP)—
RFA OH–20–001, Miner Safety and
Health Training Program Western
United States.
Date: May 5, 2020.
Time: 1:00 p.m.–5:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Marilyn Ridenour, B.S.N., M.P.H.,
Scientific Reviewer Officer, Office of
Extramural Programs, CDC, 1095
Willowdale Road, Morgantown, West
Virginia 26506, Telephone: (304) 285–
5879, dvn7@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–02693 Filed 2–10–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[OMB #0970–0505]
Submission for OMB Review;
Procedural Justice-Informed
Alternatives to Contempt
Demonstration Project Data Collection
Office of Child Support
Enforcement; Administration for
Children and Families; HHS.
ACTION: Request for public comment.
AGENCY:
The Office of Child Support
Enforcement (OCSE), Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS), is proposing to collect
data as part of the rigorous evaluation of
the Procedural Justice-Informed
Alternatives to Contempt (PJAC)
demonstration.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
Comments due within 30 days of
publication. OMB is required to make a
decision concerning the collection of
information between 30 and 60 days
after publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
DATES:
VerDate Sep<11>2014
18:19 Feb 10, 2020
Jkt 250001
if OMB receives it within 30 days of
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
directly to the following: Office of
Management and Budget, Paperwork
Reduction Project, Email: OIRA_
SUBMISSION@OMB.EOP.GOV, Attn:
Desk Officer for the Administration for
Children and Families.
Copies of the proposed collection may
be obtained by emailing infocollection@
acf.hhs.gov. Alternatively, copies can
also be obtained by writing to the
Administration for Children and
Families, Office of Planning, Research,
and Evaluation, 330 C Street SW,
Washington, DC 20201, Attn: OPRE
Reports Clearance Officer. All requests,
emailed or written, should be identified
by the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: The Office of Child
Support Enforcement (OCSE) within the
Administration for Children and
Families (ACF) is proposing a data
collection activity as part of the
Procedural Justice-Informed
Alternatives to Contempt (PJAC)
Demonstration. In September 2016,
OCSE issued grants to five state child
support agencies to provide alternative
approaches to the contempt process
with the goal of increasing noncustodial
parents’ compliance with child support
orders by building trust and confidence
in the child support agency and its
processes. OCSE also awarded a grant to
support a rigorous evaluation of PJAC.
The PJAC Demonstration is a five-year
project that allows grantees and OCSE to
learn whether incorporating principles
of procedural justice into child support
business practices increases reliable
child support payments, reduces
arrears, minimizes the need for
continued enforcement actions and
sanctions, and reduces the use of
contempt proceedings.
The PJAC demonstration will yield
information about the efficacy of
applying procedural justice principles
via a set of alternative services to the
current use of a civil contempt process
to address nonpayment of child support.
It will generate knowledge regarding
how the PJAC intervention operates, the
effects the alternative services have, and
whether the benefits of this approach
exceed the costs. The information
gathered will help inform future policy
decisions related to the contempt
process within the field of child support
enforcement.
PJAC demonstration will include
three interconnected evaluation
components:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
1. Implementation Study. The
implementation study will provide a
detailed description of the PJAC
intervention—how it is implemented,
whether it was implemented as
intended, participant characteristics, the
contexts in which it is operated, how
treatment differed from the status quo,
and the implications of PJAC practices.
The study will identify the intervention
features and conditions necessary for
effective replication or improvement of
the intervention. Key elements of the
implementation study include: A
Management Information System (MIS)
for random assignment and data
collection on participant engagement in
PJAC activities; semi-structured
interviews with staff from child support
agencies and selected partner
organizations; separate semi-structured
interviews with study participants and
the custodial parents connected to their
child support case to learn about their
experiences with and perceptions of the
child support program; and a staff
questionnaire to gather quantitative
information on the implementation of
PJAC services and staff experiences.
2. Impact Study. The impact study
will provide rigorous estimates of the
effectiveness of the PJAC intervention
using an experimental research design.
Noncustodial parents whose cases are
being referred to the contempt process
will be randomly assigned to either a
program group that is offered PJAC
services or to a control group that is
offered business-as-usual services.
Random assignment will require child
support program staff to complete a
brief data entry protocol. The impact
study will rely on administrative data
from state and county child support
programs, court records, criminal justice
records, and data from the National
Directory of New Hires. Administrative
records data will be used to estimate
impacts on child support payments,
enforcement actions, contempt
proceedings, and jail stays.
3. Benefit-Cost Study. The benefit-cost
study will estimate the costs and
benefits associated with the
implementation and impact of the PJAC
interventions. The study will examine
the costs and benefits from the
perspective of the government,
noncustodial parents, custodial parents,
and society. Pertinent benefits and costs
will be added together to determine the
net value of the program for each
perspective. Key outcomes to be
assessed include the cost of PJAC
interventions, costs for contempt
actions, child support payments from
noncustodial parents (program and
control), court costs, and jail time,
among others. The benefit-cost study
E:\FR\FM\11FEN1.SGM
11FEN1
]]>Agencies
[Federal Register Volume 85, Number 28 (Tuesday, February 11, 2020)]
[Notices]
[Pages 7761-7762]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02693]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
[[Page 7762]]
Control Special Emphasis Panel (SEP)--RFA OH-20-001, Miner Safety and
Health Training Program Western United States.
Date: May 5, 2020.
Time: 1:00 p.m.-5:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Marilyn Ridenour, B.S.N., M.P.H.,
Scientific Reviewer Officer, Office of Extramural Programs, CDC, 1095
Willowdale Road, Morgantown, West Virginia 26506, Telephone: (304) 285-
5879, [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-02693 Filed 2-10-20; 8:45 am]
BILLING CODE 4163-18-P
